Quanterix Corporation Wins Five Best Places to Work Awards from Comparably | Business

BILLERICA, Mass.–(BUSINESS WIRE)–February 28, 2022–

Quanterix Corporation (NASDAQ: QTRX), a company that digitizes biomarker analysis with the goal of advancing the science of precision health, today announced that it has been recognized by the venue’s leading culture platform of work and corporate brand reputation, comparably, in its 2021 Best Places to Work Awards. Based on more than 1,000 reviews and 40 participants within Quanterix, the company reaped awards in the following five categories: Best Company for Diversity, Best Company for Women, Best Company Culture, Best Corporate Happiness and Better Corporate Compensation.

“Every day, our diverse group of employees come together to propel our precision health mission, and I remain impressed with their passion, dedication and commitment,” said Kevin Hrusovsky, president and CEO of Quanterix. “These five awards have special meaning because they were determined and voted on by this extraordinary group. As our company continues to grow and acquire exceptional talent, fostering an inclusive work environment where everyone feels safe, empowered and valued will remain a top priority.

Comparatively, it has the most comprehensive data on what it’s like to work in organizations, with over 15 million reviews on 70,000 companies. Its 2021 Best Places to Work Awards were derived from sentiment ratings and feedback provided by employees who anonymously rated their employers on Comparably.com over a 12-month period (March 22, 2020 to March 22, 2021) on the leadership from their CEO, as well as insight into their working environment.

“We are extremely proud to be recognized in the vital areas of culture, happiness and compensation, and to have created an environment where female and diverse employees can thrive. We look forward to continuing to pursue opportunities that will allow our team to grow and feel supported,” said Denise Chittick, SPHR, Chief People Officer, Quanterix.

For more information, see Quanterix’s Comparably profile at www.comparably.com/companies/Quanterix.

About comparably

Comparably (www.comparably.com) is a leading workplace culture and compensation monitoring site that provides the most comprehensive and accurate representation of what it is like to work at companies. Employees can access salary data and anonymously rate their workplaces in nearly 20 different cultural categories, providing the public with transparent and in-depth insight into workers’ experiences based on gender, ethnicity, their age, seniority, industry, location and education. Since its launch in 2016, Comparably has accumulated 10 million employee reviews from 60,000 North American companies. It has become one of the most widely used SaaS solutions for employer branding and one of the most trusted third-party sites for salary data and workplace culture. For the most cited studies on workplace culture and compensation, including Comparably’s annual workplace culture awards: www.comparably.com/news.

About Quanterix

Quanterix is ​​a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way healthcare is delivered today by giving researchers the ability to look closely at the health-to-illness continuum. Quanterix’s technology is designed to enable much earlier disease detection, better prognoses, and improved treatment methods to improve people’s quality of life and longevity for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. For more information, visit https://www.quanterix.com.

Forward-looking statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.” and similar expressions (as well as other words or expressions that refer to future events, conditions or circumstances) are intended to identify the forward-looking statements. The forward-looking statements contained in this press release are based on Quanterix’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that could cause a difference between Quanterix’s actual results and those expressed or implied by the forward-looking statements in this press release are discussed in Quanterix’s filings with the United States Securities and Exchange Commission, including the “Factors in Risk” contained herein. Except as required by law, Quanterix assumes no obligation gation to update the forward-looking statements contained herein to reflect any changes in expectations, even when new information becomes available.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220228006014/en/

CONTACT: Media contact:

PAN Communications

Paige Romine, 321-652-8370

pan.quanterix@pancomm.comInvestor Relations:

Etienne Hrusovsky

(774) 278-0496

shrusovsky@quanterix.com

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: DATA MANAGEMENT HEALTH TECHNOLOGY OTHER TECHNOLOGIES GENERAL HEALTH RESEARCH SCIENCE

SOURCE: Quanterix Corporation

Copyright BusinessWire 2022.

PUBLISHED: 2/28/2022 2:29 PM / DISK: 2/28/2022 2:29 PM

http://www.businesswire.com/news/home/20220228006014/en

Copyright BusinessWire 2022.

Luisa D. Fuller